Sign up to save your podcasts
Or
Share The Long Run with Luke Timmerman
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Long Run with Luke Timmerman
By Timmerman ReportScience
Based on Podcast App listening data
The Long Run with Luke Timmerman episodes
- Ep180: John Rinn on Discovering Drugs Based on Long Non-Coding RNAJohn Rinn, professor at the University of Colorado and co-founder of Lincswitch Therapeutics, on exploring long non-coding RNA.1 hr 11 min
- Ep179: Ethan Weiss & Josh Lehrer on a New Idea for Cardiovascular Disease & DiabetesMarea Therapeutics CEO Josh Lehrer and CSO Ethan Weiss on a new angle of attack against cardiovascular disease and diabetes.1 hr 4 min
- Ep178: Peyton Greenside on ML-Guided Biologics DiscoveryPeyton Greenside, co-founder and CEO of BigHat Biosciences, on machine-learning guided biologic drug discovery.1 hr 3 min
- Ep177: Kevin Parker on Finding Cancer Drug TargetsKevin Parker, CEO of Cartography Biosciences, on finding new cancer drug targets.59 min
- Ep176: David Roblin on Building a TechBio CompanyDavid Roblin, CEO of London-based Relation Therapeutics, on building a techbio discovery company.1 hr 20 min
- Ep175: Andy Scharenberg on in vivo CAR-T cell therapiesAndy Scharenberg, CEO of Seattle-based Umoja Biopharma, on developing in vivo CAR-T cell therapies.1 hr 11 min
- Ep174: Najat Khan on the TechBio MovementNajat Khan, chief R&D and chief commercial officer of Recursion, on using technology to improve drug discovery.1 hr 8 min
- Ep173: Robert Blum on Building a Fully Integrated Biopharma For Muscle DisordersRobert Blum, CEO of South San Francisco-based Cytokinetics, on building a fully integrated biopharma to treat muscle disorders.58 min
- Ep172: Mostafa Ronaghi on Studying Live Cells at ScaleMostafa Ronaghi, co-founder and executive board member of Cellanome, on developing technology to look at live cells and cellular interactions at scale.1 hr 21 min
- Ep171: Ram Aiyar on RNA Editing MedicinesRam Aiyar, CEO of Cambridge, Mass.-based Korro Bio, on RNA editing medicines.1 hr 2 min
About The Long Run with Luke Timmerman
From the publisher's feed
"The Long Run"
Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.
Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Best of The Long Run with Luke Timmerman
Ranked by our users in the last 21 days
More shows like The Long Run with Luke Timmerman
Freakonomics Radio
32,058 Listeners
Odd Lots
1,982 Listeners
The a16z Show
1,089 Listeners
About Men Radio
15 Listeners
The Bio Report
39 Listeners
How I Built This with Guy Raz
30,169 Listeners
POP | TECH | JAM
78 Listeners
Strings and Things
5 Listeners
The Readout Loud
333 Listeners
The Journal.
6,075 Listeners
Biotech 2050 Podcast
62 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
10,182 Listeners
Business Of Biotech
84 Listeners
BioCentury This Week
35 Listeners
Raising Health
149 Listeners
Biotech Hangout
21 Listeners
The BioCentury Show
12 Listeners
The Workup
0 Listeners
Cheeky Pint
49 Listeners